IKKβ regulates endothelial thrombomodulin in a Klf2-dependent manner

Area of Science:

• Molecular biology
• Cell signaling
• Vascular biology

Background:

• Endothelial thrombomodulin (TM) is vital for anticoagulation and anti-inflammation.
• Tumor necrosis factor alpha (TNFα) suppresses TM expression, impacting vascular health.
• The precise mechanism of TNFα-induced TM suppression, particularly the role of NF-κB, remains debated.

Purpose of the Study:

• To investigate the role of inhibitory kappa-B kinase-beta (IKKβ) in regulating TM expression and function.
• To determine if IKKβ influences TM expression independently of the canonical NF-κB pathway.
• To elucidate the downstream mediators of IKKβ-dependent TM regulation.

Main Methods:

• Utilized chemical inhibitors, siRNA, and shRNA to inhibit IKKβ.
• Assessed TM expression via qRT-PCR, Western blot, flow cytometry, and luciferase reporter assays.
• Investigated protein interactions using chromatin immunoprecipitation (ChIP) and NF-κB activation via immunocytochemistry.

Main Results:

• IKKβ inhibition increased TM expression and function, counteracting TNFα effects.
• Downstream NF-κB members p50 and p65 did not mediate IKKβ's effect on TM.
• Knockdown of cRel and RelB, and importantly Klf2, affected TM expression, with Klf2 directly binding the TM promoter.

Conclusions:

• IKKβ regulates TM expression and function through a Klf2-dependent mechanism.
• This pathway operates independently of canonical NF-κB activation (p50/p65).
• Findings reveal a novel regulatory axis for TM, with therapeutic implications for vascular diseases.